Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
|---|---|---|---|---|---|
| CD9-H5222 | Human | Human CD69 / CLEC2C Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Triclabendazole | EGA-230B; CGA-89317; NVP-EGA230 | Approved | Novartis Pharma Ag | Egaten, Fasinex, Triclathera | United States | Fascioliasis | Novartis Pharma Ag | 1989-01-01 | Fascioliasis | Details |
| Decitabine/Cedazuridine | ASTX-727; E-7727/decitabine; Decitabine/E7727 | Approved | Astex Pharmaceuticals Inc | Inqovi | United States | Myelodysplastic Syndromes | Otsuka Pharmaceutical Co Ltd | 2020-07-07 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Solid tumours; Leukemia; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Leukemia, Myeloid, Acute; Glioma; Nervous System Neoplasms; Neurilemmoma | Details |
| Mecobalamin | E-0302 | Approved | Myelogen, Naso B12, NASOCOBAL, Methycobal, 弥尔神, 悦敏兴, RHINOCOBAL, 奇信, 曲力, 弥可保 | Peripheral Nervous System Diseases; Autistic Disorder; Neuralgia; Neuritis; Vitamin B 12 Deficiency; Amyotrophic Lateral Sclerosis; Fibromyalgia | Details | |||||
| Decitabine | DAC; AzadC; E-7373; 5-aza-CdR; NSC-127716 | Approved | Eisai Co Ltd | 达珂, Dacogen | EU | Leukemia, Myeloid, Acute | Janssen-Cilag International Nv | 2006-05-02 | Burkitt Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Breast Neoplasms; Neuroblastoma; Primary Myelofibrosis; Colorectal Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma; Urinary Bladder Neoplasms; Lung Neoplasms; Thyroid Neoplasms; Precancerous Conditions; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Metastasis; Thyroid Cancer, Papillary; Breast Neoplasms, Male; Melanoma; Anemia, Sickle Cell; Lymphoma, Large B-Cell, Diffuse; Solid tumours; Leukemia; Purpura, Thrombocytopenic, Idiopathic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Leukemia, Myeloid, Accelerated Phase; Leukemia, Promyelocytic, Acute; Esophageal Neoplasms; Thalassemia; Neutropenia; Myelodysplastic Syndromes; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large-Cell, Immunoblastic; Plasmacytoma; Small Cell Lung Carc | Details |
| Azacitidine | NSC-102816; 5-aza-CR; CC-486; NS-17; U-18496; NEX-18; NEX-18a | Approved | Celgene Corp | 维达莎, Vidaza, Onureg | United States | Leukemia, Myeloid, Acute | Celgene Corp | 2004-05-19 | Leukemia, Myeloid, Acute; Immune System Diseases; Prostatic Neoplasms; Tuberculosis, Pulmonary; Breast Neoplasms; Osteosarcoma; Sarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Brain Neoplasms; Primary Myelofibrosis; Hepatic Insufficiency; Multiple Myeloma; Lymphoma; Lung Neoplasms; Leukemia, Myelomonocytic, Juvenile; Thyroid Neoplasms; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung; Myelodysplastic-Myeloproliferative Diseases; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Large Granular Lymphocytic; Myelodysplastic Syndromes; Head and Neck Neoplasms; Intestinal Neoplasms; Solid tumours; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Ependymoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Leukemia, Myelomonocytic, Chronic; Leukemia; beta-Thalassemia; Lymphoma, Large B-Cell, Diffuse; Plasmacytoma; Myeloproliferative Disorders; Neoplasms; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Hodgkin Disea | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| FdCyd | NSC-48006; Ro-5-1090 | Phase 2 Clinical | City Of Hope National Medical Center, National Cancer Institute | Head and Neck Neoplasms; Esophageal Neoplasms; Neoplasms; Myelodysplastic Syndromes; Urinary Bladder Neoplasms; Mesothelioma; Breast Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
| Azacitidine/Cedazuridine | ASTX-030 | Phase 3 Clinical | Otsuka Pharmaceutical Co Ltd | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
| Decitabine/Tetrahydrouridine | EPI-01 | Phase 2 Clinical | Epicdestiny | Anemia, Sickle Cell | Details |
| Curcumin | VOLT-03; VOLT-3; NSC-32982 | Phase 3 Clinical | University Of Pennsylvania | Renal Insufficiency, Chronic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Breast Neoplasms; Oral Submucous Fibrosis; Tobacco Use Disorder; Cardiovascular Diseases; Cognitive Dysfunction; Neuralgia; Colorectal Neoplasms; Cervical Intraepithelial Neoplasia; Uterine Cervical Dysplasia; Cigarette Smoking; Asthma; Chronic Periodontitis; Lung Neoplasms; Lichen Planus, Oral; Adenocarcinoma, Mucinous; Inflammation; Osteoarthritis; Uterine Cervical Neoplasms; Aortic Aneurysm, Abdominal; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Adenocarcinoma; Neoplasm Metastasis; Macular Degeneration; Neoplasms; Drug-Related Side Effects and Adverse Reactions; Adenomatous Polyposis Coli; Optic Atrophy, Hereditary, Leber; Digestive System Diseases; Depression; Non-alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2; Gastritis, Atrophic; Radiodermatitis; Pain; Spasm; Rectal Neoplasms; Atherosclerosis; Primary Dysautonomias; Arthritis, Rheumatoid; Spondylitis, An | Details |
| Guadecitabine Sodium | SGI-110; S-110; 0RB89YH367 (UNII code) | Phase 2 Clinical | Otsuka Holdings Co Ltd | Klatskin Tumor; Adenocarcinoma; Paraganglioma; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Gallbladder Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Peritoneal Neoplasms; Cholangiocarcinoma; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Myeloproliferative Disorders; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Stomach Neoplasms; Carcinoma, Renal Cell; Pheochromocytoma; Kidney Neoplasms; Chondrosarcoma | Details |
| EF-009 | EF-009 | Phase 2 Clinical | Everfront Biotech Co Ltd | Pancreatic Neoplasms | Details |
| NTX-301 | NTX-303 | Phase 2 Clinical | Southern Research Institute, Pinotbio Inc | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
